Clinical Trial Update: Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gefitinib (Iressa) in combination with docetaxel (Taxotere) for metastatic urothelial cancer (bladder cancer) was terminated; results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma

Drugs mentioned

• Iressa (gefitinib)
• Taxotere (docetaxel)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Bladder Cancer | Phase 2 | Status: TERMINATED | Results posted: 2015-10-06